 half maximal inhibitory concentrations (IC50) substituted benzimidazoles H+, K(+)-ATPase hog gastric vesicles measured using pyruvate kinase-lactate dehydrogenase-linked system hydrolysis ATP coupled oxidation NADH. vesicles incubated solution containing high concentration KCl, valinomycin Mg-ATP, intravesicular medium acidified. inhibitor activated acidic medium reacted SH groups luminal (intravesicular) side ATPase. active compound formed extravesicular medium (pH 6.11) quenched GSH. conditions, IC50 new compound E3810, 2[(4-(3-methoxypropoxy)-3-methylpyridine-2-yl)methyl-sulfinyl]-1H- benzimidazole sodium salt, 0.072 microM omeprazole 0.47 microM 25 degrees. hand, rates formation active compounds, tetracyclic sulfenamide derivatives, original substituted benzimidazoles 0.1 N HCl (k) determined measuring optical density characteristic wavelengths active compounds. good correlation IC50 k various substituted benzimidazoles including E3810, methoxy derivative E3810, omeprazole, Ro 18-5364, H compound, picoprazole timoprazole. fact suggest rate formation acid-activated compound main factor determining potency inhibitor.